Two Sigma Advisers’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-74,100
Closed -$206K 2788
2022
Q3
$206K Sell
74,100
-77,300
-51% -$188K ﹤0.01% 2191
2022
Q2
$186K Buy
151,400
+121,700
+410% +$204K ﹤0.01% 2296
2022
Q1
$86K Buy
+29,700
New +$126K ﹤0.01% 2528

Two Sigma Advisers's ZY Position: Q4 2022 in Review

Two Sigma Advisers sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 74,100 shares — an estimated $206K sold.

Two Sigma Advisers first reported a position in ZY in Q1 2022 and held it in 3 quarters. The position peaked at $206K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Two Sigma Advisers reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 74,100 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $206K.
  • Two Sigma Advisers first reported a position in Zymergen Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Two Sigma Advisers's Zymergen Inc. Common Stock position peaked at $206K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.